New Combination of Asthma Drugs Could Help Those Suffering from the Disease

Share Article

Salt Lake City-based Optimum Clinical Research is seeking participants who have asthma to try the new medication.

Optimum-Clinical-Research

Salt Lake City-based Optimum Clinical Research is currently screening asthma sufferers to participate in a health study at the clinic. Photo courtesy of Life Style Health

Asthma symptoms cause a major impact on those who are struggling with the disease, sometimes limiting their ability to engage in day-to-day activities. It’s not uncommon for asthma to cause missed school and work days.

The “Asthma in Utah Burden Report 2012” recently found that 240,000 Utahns have asthma. This accounts for 9 percent of adults and 7 percent of children in the state. The asthma diagnosis rate among adults in the state has risen by 29 percent more than the past nine years. Salt Lake City-based Optimum Clinical Research is currently conducting a study that could help Utahns who are struggling with the disease.

The study is examining whether two already approved medications can work in combination to reduce symptoms including coughing, wheezing, breathlessness and tightness in the chest.
The medication combination will hopefully help patients avoid major asthma-related complications, which might include hospitalization, a need for supplemental prednisone and in the most severe cases, an asthma related death.

Click here to learn more about the asthma research and other studies under way at Optimum Clinical Research.

“Asthma symptoms cause a major impact on those who are struggling with the disease, sometimes limiting their ability to engage in day-to-day activities. It’s not uncommon for asthma to cause missed school and work days,” said Jared Shields, recruitment coordinator at Optimum Clinical Research.

Optimum Clinical Research is currently seeking participants for the asthma study. Visit ocresearch.com to learn more about this and other clinical studies currently being conducted at the clinic.

Eligible participants for the Asthma study must meet the following qualifications:

  •     Be 18 years of age or older
  •     Diagnosed with persistent asthma
  •     Have either received oral prednisone or have been hospitalized for asthma within the last year

The benefits of participating in the clinical study include a $50 payment per visit, with Albuterol and all study medications provided. There is no cost to participate and insurance is not needed. Participation in the study is on a completely voluntary basis. There is no obligation to continue participating.

For more information about the study, visit ocresearch.com or call 801-363-7353.

On average, about 20 Utahns per day need medical assistance for asthma-related problems. In 2010, asthma-related hospitalizations cost Utahns $16.2 million. Poor air quality, tobacco smoke and other environmental factors are all known to trigger asthma attacks.

“There isn’t a cure for asthma, but there are a lot of options to help control symptoms and prevent major asthma-related complications,” Shields said. “I believe this study could present one of the next best treatment options doctors will turn to for treating asthma.”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Pat Parkinson
Follow us on
Visit website

Media

Optimum-Clinical-Research